Human leukocyte antigens and adult acute myeloid leukemia: A first report from Lebanon

dc.contributor.authorEl Achkar, Hani
dc.contributor.authorTamim, Hani Mohammed
dc.contributor.authorEl Karaaoui, Abdul Karim
dc.contributor.authorFermanian, Puzant
dc.contributor.authorKeleshian, Sose H.
dc.contributor.authorAbbas, Fatmeh Ibrahim
dc.contributor.authorMahfouz, Rami A.R.
dc.contributor.departmentPathology and Laboratory Medicine
dc.contributor.departmentInternal Medicine
dc.contributor.facultyFaculty of Medicine (FM)
dc.contributor.institutionAmerican University of Beirut
dc.date.accessioned2025-01-24T12:10:15Z
dc.date.available2025-01-24T12:10:15Z
dc.date.issued2023
dc.description.abstractIntroduction: Acute Myeloid Leukemia (AML) represents the most common type of acute leukemia in adults and the second most common form of leukemia in general. AML has been associated with HLA alleles and these correlations have been widely investigated worldwide. Objective: The aim of this study is to analyze the antigen frequency of HLA Class I (HLA-A, HLA[sbnd]B, and HLA[sbnd]C) and Class II (HLA-DRB1 and HLA-DQB1) among AML Lebanese adult patients. Methods: This is a retrospective study reviewing all the HLA results of 121 adult patients admitted to the American University of Beirut Medical Center (AUBMC) from January 2017 to May 2022. Comparison of HLA frequency in AML patients to frequency in general Lebanese population published in previous studies was done. Results: In HLA class I, an increased frequency of HLA-A*03 (OR, 1.61; 95% CI, 1.10 to 2.37; P = 0.02), HLA-A*25 (OR, 6.69; 95% CI, 1.78 to 25.07; P = 0.01), HLA-A*74 (OR, 8.33; 95% CI, 1.67 to 41.51; P = 0.02) was found in the AML group, whereas decreased frequency of HLA-B*15 (OR, 0.22; 95% CI, 0.05 to 0.93; P = 0.03) was noted. In HLA class II, DRB1*03 (OR, 0.27; 95% CI, 0.14 to 0.50; P < 0.001) was higher among the control group and DRB1*12 (OR, 15.71; 95% CI, 1.88 to 131.20; P = 0.01) among the AML group. Conclusion: Findings revealed that three class I HLA antigens are predisposing to AML (HLA-A*03; HLA-A*25; HLA-A*74) and one class I HLA antigen is protective (HLA-B*15). Regarding class II HLA antigens, DRB1*03 was found to be protective whereas DRB1*12 was found to be predisposing to AML. © 2023 Elsevier B.V.
dc.identifier.doihttps://doi.org/10.1016/j.humgen.2023.201159
dc.identifier.eid2-s2.0-85150387422
dc.identifier.urihttp://hdl.handle.net/10938/32295
dc.language.isoen
dc.publisherElsevier B.V.
dc.relation.ispartofHuman Gene
dc.sourceScopus
dc.subjectAdults
dc.subjectAml
dc.subjectAntigens
dc.subjectFrequency
dc.subjectHla
dc.subjectLebanon
dc.subjectHla a antigen
dc.subjectHla antigen
dc.subjectHla b antigen
dc.subjectHla c antigen
dc.subjectHla dqb1 antigen
dc.subjectHla drb1 antigen
dc.subjectPhycoerythrin
dc.subjectAcute myeloid leukemia
dc.subjectAdult
dc.subjectArticle
dc.subjectControlled study
dc.subjectDna fingerprinting
dc.subjectGene frequency
dc.subjectGenetic polymorphism
dc.subjectGenetic variability
dc.subjectHematopoietic stem cell transplantation
dc.subjectHla typing
dc.subjectHuman
dc.subjectMajor clinical study
dc.subjectPolymerase chain reaction
dc.subjectProtein expression
dc.subjectRetrospective study
dc.titleHuman leukocyte antigens and adult acute myeloid leukemia: A first report from Lebanon
dc.typeArticle

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
2023-720.pdf
Size:
395.15 KB
Format:
Adobe Portable Document Format